| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.6 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |